RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 57.48 Million USD | 20.66% |
| 2021 | 47.64 Million USD | -78.5% |
| 2020 | 221.61 Million USD | -18.91% |
| 2019 | 273.29 Million USD | 1.66% |
| 2018 | 268.83 Million USD | -16.17% |
| 2017 | 320.68 Million USD | -2.53% |
| 2016 | 329.02 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | 57.75 Million USD | 0.45% |
| 2023 Q2 | 58.14 Million USD | 0.69% |
| 2022 Q3 | 56.66 Million USD | 27.59% |
| 2022 Q2 | 44.4 Million USD | -7.06% |
| 2022 FY | 57.48 Million USD | 20.66% |
| 2022 Q1 | 47.78 Million USD | 0.28% |
| 2022 Q4 | 57.48 Million USD | 1.46% |
| 2021 Q4 | 47.64 Million USD | 50.48% |
| 2021 FY | 47.64 Million USD | -78.5% |
| 2021 Q3 | 31.66 Million USD | 0.0% |
| 2020 FY | 221.61 Million USD | -18.91% |
| 2019 FY | 273.29 Million USD | 1.66% |
| 2018 FY | 268.83 Million USD | -16.17% |
| 2017 FY | 320.68 Million USD | -2.53% |
| 2016 FY | 329.02 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ContraFect Corporation | 2.88 Million USD | -1895.453% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -28556.239% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -40523.101% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -4178.78% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -39.526% |
| Kadimastem Ltd | 891.22 Thousand USD | -6350.552% |
| Zenith Capital Corp. | 10.22 Thousand USD | -562139.609% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -15882.041% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -342.325% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -14206.12% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -3874.849% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -93.129% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -5962.507% |
| Qrons Inc. | 351.84 Thousand USD | -16239.204% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -2022.381% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -2297.649% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -3746.059% |
| Affymax, Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 15.011% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -879.188% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -916.002% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | 735.54 Thousand USD | -7715.869% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -182.807% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -4580.139% |
| CytoDyn Inc. | 30.07 Million USD | -91.146% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -32.546% |
| IMV Inc. | 28.88 Million USD | -99.035% |
| Genus plc | 233.1 Million USD | 75.337% |
| Halberd Corporation | 150 Thousand USD | -38226.0% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -1294.702% |
| LadRx Corporation | 33.6 Thousand USD | -170967.666% |
| Marizyme, Inc. | 18.71 Million USD | -207.14% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -73.678% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -42331.377% |
| Q BioMed Inc. | 4.1 Million USD | -1298.766% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -7502.314% |
| Enzolytics Inc. | 996.33 Thousand USD | -5670.03% |
| CSL Limited | 12.18 Billion USD | 99.528% |
| Skye Bioscience, Inc. | 4.61 Million USD | -1145.627% |
| SQZ Biotechnologies Company | 27.47 Million USD | -109.272% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -6373.52% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -1861.822% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -24972.506% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -712.817% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -7565.2% |
| NovAccess Global Inc. | 2.19 Million USD | -2513.279% |
| HST Global, Inc. | 98.31 Thousand USD | -58371.913% |
| SYBLEU INC | 477.5 Thousand USD | -11939.581% |
| Alpha Cognition Inc. | 1.22 Million USD | -4610.777% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Mesoblast Limited | 118.7 Million USD | 51.568% |
| MultiCell Technologies, Inc. | 202.58 USD | -28378318.403% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -2371.63% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -223427.353% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -9024.123% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 66.488% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -2445.585% |
| GB Sciences, Inc. | 1.75 Million USD | -3167.707% |
| argenx SE | 20 Million USD | -187.445% |
| Resverlogix Corp. | 6.49 Million USD | -785.672% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -22392.488% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -26.183% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -1799.715% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| ONE Bio Corp. | 19.71 Million USD | -191.6% |
| Genscript Biotech Corporation | 417.73 Million USD | 86.238% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -38573.026% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -23013.943% |
| Agentix Corp. | 50 Thousand USD | -114878.0% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -1120.206% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -22878.871% |
| Cell Source, Inc. | 9.25 Million USD | -521.222% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -7502.314% |
| Itoco Inc. | 228.37 Thousand USD | -25072.85% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -27149.2% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -1053.703% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -635.157% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -46829.796% |
| Rebus Holdings, Inc. | 310 Thousand USD | -18444.839% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -1114.057% |
| Mobile Lads Corp. | 484.28 Thousand USD | -11770.927% |
| International Stem Cell Corporation | 4.17 Million USD | -1275.993% |
| Bioxytran, Inc. | 1.92 Million USD | -2886.442% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -92010.618% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -2536.022% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -591.306% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -569.645% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -3595.903% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -21351.119% |
| Neutra Corp. | 54.15 Thousand USD | -106054.443% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -3041.475% |
| PureTech Health plc | 25.51 Million USD | -125.341% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -4595.947% |
| IXICO plc | 472.02 Thousand USD | -12079.279% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -270.873% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 7.667% |
| CSL Limited | 12.18 Billion USD | 99.528% |
| Cellectis S.A. | 92.77 Million USD | 38.035% |